Rubra Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Na, Telangana, India, established in 1995.
1995 Na, Telangana, India Active
Last Updated:
Access Report
About Rubra Pharmaceuticals Limited

Rubra Pharmaceuticals Limited, a active public limited company, was established on 31 May 1995 in Na, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24200TG1995PLC020538. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Nirupa Gupta (Director), Narender Kumar Gupta (Director), Kapil Gupta (Director). It holds ₹9.60 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 4-3-64/1, Raghunath Bagh.K.S.Lane, Sultan Bazar, Hyderabad., Na, Telangana.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24200TG1995PLC020538

  • Registration Number

    020538

  • Incorporation Date

    31 May 1995

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 30 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 9.60 Cr
  • Revenue Growth **** 4.08%
  • Profit Growth **** 41.97%
  • Ebitda **** 5.82%
  • Net Worth 23.54%
  • Total Assets **** 11.98%
Company report

Rubra Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rubra Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rubra Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Nirupa Gupta Director 31 May 1995 Current
Narender Kumar Gupta Director 31 May 1995 Current
Kapil Gupta Director 02 Jan 2003 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rubra Pharmaceuticals.

Rubra Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.08% increase. The company also saw a substantial improvement in profitability, with a 41.97% increase in profit. The company's net worth Soared by an impressive increase of 23.54%.

Rubra Pharmaceuticals revenue growth over time
Rubra Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 4.08%
*******
*******
*******
*******
Revenue from Operations
*******
 77.24%
*******
*******
*******
*******
Total Assets
*******
 11.98%
*******
*******
*******
*******
Profit or Loss
*******
 41.97%
*******
*******
*******
*******
Net Worth
*******
 23.54%
*******
*******
*******
*******
EBITDA
*******
 5.82%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rubra Pharmaceuticals?

In 2022, Rubra Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹96,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Bank Of Maharashtra : 9.60 Cr
Latest Charge Details
Date Lender Amount Status
20 Jul 2013 Bank Of Maharashtra ₹9.60 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Rubra Pharmaceuticals?

Unlock and access historical data on people associated with Rubra Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rubra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rubra Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rubra Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Rubra Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Rubra Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.

  • Charges

    The activity A charge with Bank Of Maharashtra amounted to Rs. 96.00 M with Charge ID 10481315 was registered on 20 Jul 2013. was completed.

  • Director Appointment

    The activity Kapil Gupta was appointed as a Director was appointed as a Director on 02 Jan 2003 & has been associated with this company since 23 years 2 months . was completed.

  • Director Appointment

    The activity Nirupa Gupta was appointed as a Director was appointed as a Director on 31 May 1995 & has been associated with this company since 30 years 9 months . was completed.

  • Director Appointment

    The activity Narender Kumar Gupta was appointed as a Director was appointed as a Director on 31 May 1995 & has been associated with this company since 30 years 9 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rubra Pharmaceuticals Limited?

The CIN of Rubra Pharmaceuticals Limited is U24200TG1995PLC020538.

Where is Rubra Pharmaceuticals Limited headquartered?

Rubra Pharmaceuticals Limited is headquartered at 4-3-64/1, Raghunath Bagh.K.S.Lane, Sultan Bazar, Hyderabad., Na, Telangana.

When was Rubra Pharmaceuticals Limited incorporated?

Rubra Pharmaceuticals Limited was incorporated on 31 May 1995.

Who are the current directors of Rubra Pharmaceuticals Limited?

The current directors of Rubra Pharmaceuticals Limited are

What is the primary industry of Rubra Pharmaceuticals Limited?

The primary industry of Rubra Pharmaceuticals Limited is Trade.

Is Rubra Pharmaceuticals Limited a listed company?

Rubra Pharmaceuticals Limited is unlisted.

What is the capital structure of Rubra Pharmaceuticals Limited?

The authorized capital of Rubra Pharmaceuticals Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Rubra Pharmaceuticals Limited?

The compliance status of Rubra Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available